Author

Grant R. Seeger

Observed names: G. R. Seeger, G.R. Seeger, Grant Seeger

Observed institutions: University of South Carolina Upstate, Mayo Clinic, Altru Health System, Michigan Cancer Research Consortium, St. Luke's Hospital

OpenAlex ID: A5081670477

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

2022 · C.E. Geyer, J.E. Garber, et al. · Annals of Oncology · 480

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

2017 · Harpreet S Wasan, Peter Gibbs, et al. · The Lancet Oncology · 404

Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2

2013 · D. L. Barton, H. Liu, et al. · JNCI Journal of the National Cancer Institute · 300

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

2018 · Peter Gibbs, Volker Heinemann, et al. · Clinical Colorectal Cancer · 68

N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

2016 · Robert C. Miller, Daniel G. Petereit, et al. · International Journal of Radiation Oncology*Biology*Physics · 21

N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2)

2019 · Terence T. Sio, Miran J. Blanchard, et al. · Mayo Clinic Proceedings · 16

Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial.

2012 · Robert R. McWilliams, Michelle R. Mahoney, et al. · Journal of Clinical Oncology · 10

Phase III evaluation of American ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N07C2.

2012 · Debra L. Barton, Heshan Liu, et al. · Journal of Clinical Oncology · 8

Primary and Secondary Endpoint Analysis of N08C9 (Alliance): A Phase 3 Randomized Trial of Sulfasalazine Versus Placebo in the Prevention of Acute Radiation Enteritis

2014 · R.C. Miller, D.G. Petereit, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

N08C9 (Alliance) - A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

2013 · R.C. Miller, D.G. Petereit, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

Works count: 10

Citation count: 1,309

H-index: 8

I10-index: 7